Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease

▶ No clearly pathogenic mutations were identified in ATP13A2 and GIGYF2. ▶ We identified a higher frequency of mutations in GBA among PD cases than controls. ▶ GIGYF2 and ATP13A2 do not seem to contribute to PD in Brazilian patients. ▶ Our results support an association between GBA mutations and PD....

Full description

Saved in:
Bibliographic Details
Published in:Neuroscience letters Vol. 485; no. 2; pp. 121 - 124
Main Authors: dos Santos, Adriana Vaz, Pestana, Cristiane Pinheiro, Diniz, Karen Rafaella da Silva, Campos, Mário, Abdalla-Carvalho, Cláudia Bueno, de Rosso, Ana Lúcia Zuma, Pereira, João Santos, Nicaretta, Denise Hack, de Carvalho, William Luciano, dos Santos, Jussara Mendonça, Santos-Rebouças, Cíntia Barros, Pimentel, Márcia Mattos Gonçalves
Format: Journal Article
Language:English
Published: Ireland Elsevier Ireland Ltd 19-11-2010
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:▶ No clearly pathogenic mutations were identified in ATP13A2 and GIGYF2. ▶ We identified a higher frequency of mutations in GBA among PD cases than controls. ▶ GIGYF2 and ATP13A2 do not seem to contribute to PD in Brazilian patients. ▶ Our results support an association between GBA mutations and PD. In the last decade, several genes have been linked to Parkinson's disease (PD), including GIGYF2, ATP13A2 and GBA. To explore whether mutations in these genes contribute to development of PD in the Brazilian population, we screened 110 patients with early-onset PD. No clearly pathogenic mutations were identified in ATP13A2 and GIGYF2. In contrast, we identified a significantly higher frequency of known pathogenic mutations in GBA gene among the PD cases (6/110 = 5.4%) when compared to the control group (0/155) ( P = 0.0047). Our results strongly support an association between GBA gene mutations and an increased risk of PD. Mutations in GIGYF2 and ATP13A2 do not seem to represent a risk factor to the development of PD in the Brazilian population. Considering the scarcity of studies on GIGYF2, ATP13A2 and GBA mutation frequency in Latin American countries, we present significant data about the contribution of these genes to PD susceptibility.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0304-3940
1872-7972
DOI:10.1016/j.neulet.2010.08.083